Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
Jing WangYan DuYu KangPublished in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)
In contrast to ovarian cancer, women with BOT were not more prone to develop SPM.